SCHEMBL883418

SCHEMBL883418

Cc1cccc(N(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.50
LMNA P02545 2/20 0.46
TSHR P16473 1/20 0.46
ALOX12 P18054 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45
ALDH1A1 P00352 4/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 3/20 0.44
MAPT P10636 3/20 0.44
CYP1A2 P05177 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP2D6 P10635 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
JAK2 O60674 1/20 0.44
HTT P42858 1/20 0.44
PAX8 Q06710 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27706354 1.00 ACHE (0.50) ACHELMNATSHRALOX12NPSR1
SCHEMBL6870036 1.00 ACHE (0.50) ACHELMNATSHRALOX12NPSR1
Benzene SCHEMBL13561466 1.00 ACHE (0.50) ACHELMNATSHRALOX12NPSR1
SCHEMBL10039954 0.98 ALDH1A1 (0.48) ACHELMNATSHRALOX12NPSR1
SCHEMBL13017732 0.98 ALDH1A1 (0.48) ACHELMNATSHRALOX12NPSR1
SCHEMBL8765594 0.98 ACHE (0.48) ACHELMNATSHRALOX12NPSR1
SCHEMBL13886460 0.98 ALDH1A1 (0.48) ACHELMNATSHRALOX12NPSR1
SCHEMBL22812841 0.98 ALDH1A1 (0.48) ACHELMNATSHRALOX12NPSR1
SCHEMBL26563 0.98 ALDH1A1 (0.48) ACHELMNATSHRALOX12NPSR1
SCHEMBL10065551 0.98 ALDH1A1 (0.48) ACHELMNATSHRALOX12NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12382778-B2 Organic electroluminescent device, display panel and display apparatus BOE TECHNOLOGY GROUP CO., LTD. (CN) 2025-08-05 US claimed
CN-117821020-A Composite cooling medium composition and preparation method and application thereof 润威新材料科技(上海)有限公司 2024-04-05 CN claimed
US-20220302404-A1 ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY PANEL AND DISPLAY APPARATUS BOE TECHNOLOGY GROUP CO., LTD. (CN) 2022-09-22 US claimed
CN-112928228-A Functional material, light-emitting substrate, preparation method of light-emitting substrate and light-emitting device 京东方科技集团股份有限公司 2021-06-08 CN claimed
CN-111554821-A Organic electroluminescent device, display panel and display device 京东方科技集团股份有限公司 2020-08-18 CN claimed
CN-1911897-A Method of synthesizing TPD kind photoelectric material HANDAN OPTICAL GUIDE HEAVY IND (CN) 2007-02-14 CN claimed
JP-11199549-A None JP disclosed
US-12382778-B2 Organic electroluminescent device, display panel and display apparatus BOE TECHNOLOGY GROUP CO., LTD. (CN) 2025-08-05 US disclosed
CN-113437241-B Display substrate, display device and preparation method of display substrate 京东方科技集团股份有限公司 2024-07-16 CN disclosed
CN-113555407-B Organic electroluminescent display substrate, preparation method thereof and display device 合肥京东方卓印科技有限公司 2024-06-11 CN disclosed
CN-113097402-B Organic electroluminescent device, preparation method thereof and display panel 京东方科技集团股份有限公司 2024-04-16 CN disclosed
US-20240074306-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2024-02-29 US disclosed
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 US disclosed
CN-1911897-A Method of synthesizing TPD kind photoelectric material HANDAN OPTICAL GUIDE HEAVY IND (CN) 2007-02-14 CN disclosed
US-20060008672-A1 Hole-trapping materials for improved OLED efficiency EASTMAN KODAK COMPANY 2006-01-12 US disclosed
JP-2004315495-A NEW ARYLAMINE DERIVATIVE HAVING FLUORENE SKELETON, SYNTHETIC INTERMEDIATE OF THE SAME, METHOD FOR PRODUCING THEM AND ORGANIC EL ELEMENT TOSOH CORP 2004-11-11 JP disclosed
US-6043370-A REACTING AROMATIC AMINE WITH AN AROMATIC HALIDE IN PRESENCE OF COPPER CONTAINING CATALYST IN A REACTION SOLVENT HAVING IONIZATION POTENTIAL OF FROM 8.0 TO 9.0 EV. SANKIO CHEMICAL CO., LTD. (JP) 2000-03-28 US disclosed
US-4764625-A POTASSIUM HYDROXIDE, COPPER CATALYST XEROX CORPORATION (US) 1988-08-16 US disclosed
EP-0034425-B1 PROCESS FOR PREPARING ARYLAMINES XEROX CORPORATION (US) 1984-05-16 EP disclosed
EP-0034425-A2 Process for preparing arylamines XEROX CORPORATION (US) 1981-08-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917913-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 ACHE 339/4885LMNA 3497/4885TSHR 4405/4885
US-20240074306-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER CYP1B1, NOTUM, WEE1 ACHE 864/4885LMNA 1899/4885TSHR 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.